These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 20003046
1. Cryoprecipitate prepared from plasma frozen within 24 hours after phlebotomy contains acceptable levels of fibrinogen and VIIIC. Yazer MH, Triulzi DJ, Hassett AC, Kiss JE. Transfusion; 2010 May; 50(5):1014-8. PubMed ID: 20003046 [Abstract] [Full Text] [Related]
2. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Caudill JS, Nichols WL, Plumhoff EA, Schulte SL, Winters JL, Gastineau DA, Rodriguez V. Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257 [Abstract] [Full Text] [Related]
3. Coagulation factor levels in plasma frozen within 24 hours of phlebotomy over 5 days of storage at 1 to 6 degrees C. Yazer MH, Cortese-Hassett A, Triulzi DJ. Transfusion; 2008 Dec; 48(12):2525-30. PubMed ID: 18774964 [Abstract] [Full Text] [Related]
4. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems. Burnouf T, Caron C, Radosevich M, Goubran HA, Goudemand J, El-Ekiaby M. Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126 [Abstract] [Full Text] [Related]
5. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Serrano K, Scammell K, Weiss S, Culibrk B, Levin E, Gyöngyössy-Issa M, Devine DV. Transfusion; 2010 Feb; 50(2):344-53. PubMed ID: 19843287 [Abstract] [Full Text] [Related]
6. Variability in the fibrinogen and von Willebrand factor content of cryoprecipitate. Implications for reducing donor exposure. Hoffman M, Jenner P. Am J Clin Pathol; 1990 May; 93(5):694-7. PubMed ID: 2327369 [Abstract] [Full Text] [Related]
7. Influence of canine donor plasma hemostatic protein concentration on quality of cryoprecipitate. Drinkhouse M, Brooks MB, Stefanovski D, Marryott K, Callan MB. J Vet Intern Med; 2019 Jan; 33(1):124-131. PubMed ID: 30548342 [Abstract] [Full Text] [Related]
8. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Lokhandwala PM, O'Neal A, Patel EU, Brunker PAR, Gehrie EA, Zheng G, Kickler TS, Ness PM, Tobian AAR. Transfusion; 2018 May; 58(5):1126-1131. PubMed ID: 29479708 [Abstract] [Full Text] [Related]
9. The quality of fresh-frozen plasma produced from whole blood stored at 4 degrees C overnight. Cardigan R, Lawrie AS, Mackie IJ, Williamson LM. Transfusion; 2005 Aug; 45(8):1342-8. PubMed ID: 16078924 [Abstract] [Full Text] [Related]
10. Can storage of thawed cryoprecipitate be extended to more than six hours? Saxena S, Odono V, Francis RB, Endahl GL, Shulman IA. Am J Clin Pathol; 1990 Aug; 94(2):203-6. PubMed ID: 2115291 [Abstract] [Full Text] [Related]
11. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centres using a disposable bag system. Burnouf T, Goubran HA, Radosevich M, Sayed MA, Gorgy G, El-Ekiaby M. Vox Sang; 2006 Jul; 91(1):56-62. PubMed ID: 16756602 [Abstract] [Full Text] [Related]
12. Changes in coagulation factor activity and content of di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing. Sheffield WP, Bhakta V, Mastronardi C, Ramirez-Arcos S, Howe D, Jenkins C. Transfusion; 2012 Mar; 52(3):493-502. PubMed ID: 21883262 [Abstract] [Full Text] [Related]
13. Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards. Lokhandwala PM, Young PP, White J, Brown BL. Transfusion; 2022 Sep; 62(9):1731-1735. PubMed ID: 35894539 [Abstract] [Full Text] [Related]
14. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days. Buchta C, Felfernig M, Höcker P, Macher M, Körmöczi GF, Quehenberger P, Heinzl H, Knöbl P. Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070 [Abstract] [Full Text] [Related]
15. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele MC, Hsu J, Rheinschmidt M, Lin L. Transfusion; 2008 Jan; 48(1):108-17. PubMed ID: 17900283 [Abstract] [Full Text] [Related]
16. Cryoprecipitate prepared from plasma treated with methylene blue plus light: increasing the fibrinogen concentration. Hornsey VS, Young DA, Docherty A, Hughes W, Prowse CV. Transfus Med; 2004 Oct; 14(5):369-74. PubMed ID: 15500456 [Abstract] [Full Text] [Related]
17. Extending the post-thaw viability of cryoprecipitate. Thomson C, Sobieraj-Teague M, Scott D, Duncan E, Abraham S, Roxby D. Transfusion; 2021 May; 61(5):1578-1585. PubMed ID: 33728705 [Abstract] [Full Text] [Related]
18. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma. Culler CA, Iazbik C, Guillaumin J. J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):638-644. PubMed ID: 29064153 [Abstract] [Full Text] [Related]
19. Photochemical treatment of plasma with amotosalen and UVA light: process validation in three European blood centers. Schlenke P, Hervig T, Isola H, Wiesel ML, Kientz D, Pinkoski L, Singh Y, Lin L, Corash L, Cazenave JP. Transfusion; 2008 Apr; 48(4):697-705. PubMed ID: 18194378 [Abstract] [Full Text] [Related]
20. Solvent-detergent filtered (S/D-F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system. El-Ekiaby M, Sayed MA, Caron C, Burnouf S, El-Sharkawy N, Goubran H, Radosevich M, Goudemand J, Blum D, de Melo L, Soulié V, Adam J, Burnouf T. Transfus Med; 2010 Feb; 20(1):48-61. PubMed ID: 19778318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]